Work

Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies

Year: 2013

Type: article

Source: Leukemia

DOI: 10.1038/leu.2013.79

Authors: M Roschewski, M Farooqui, G Aue, F Wilhelm, A Wiestner

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, Onconova Therapeutics (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Award: G9000248136

OpenAlex ID: W2000712177

FWCI: 1.633

Cites: 14

Cited by: 21

Related to: 10